OTCM
WHTCF
Market cap794mUSD
Jul 10, Last price
3.11USD
1D
4.43%
1Q
14.00%
IPO
-90.39%
Name
WELL Health Technologies Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WELL Health Technologies Corp. is a leading digital healthcare company with operations in Canada, the United States, and internationally, primarily supporting medical professionals. The company delivers a full spectrum of patient services through various channels. These encompass general primary care; rehabilitative therapies such as physiotherapy, occupational therapy, and chiropractic services; dietary and mental health counselling; and sleep-related treatments. Furthermore, they provide specialized medical attention from gastroenterologists, a wide array of diagnostic services including cardiology, women's health, bone/muscle health, and cancer screening, alongside comprehensive telehealth options. Beyond direct patient care, WELL Health equips practitioners with a suite of technological solutions. This portfolio includes the OSCAR Pro electronic medical record (EMR) system, several virtual health platforms like Tia Health and Circle Medical, and Apps.health, a dedicated marketplace for digital health applications. They also offer Insig for virtual care and patient engagement, revenue cycle management solutions encompassing outsourced billing, and advanced cybersecurity with patient data privacy safeguards. As of December 31, 2021, the company operated 30 primary and executive care clinics, and provided core, specialized, and accredited diagnostic health services from 49 locations throughout Ontario. Established in 2010, the company was initially known as Wellness Lifestyles Inc. before adopting its current name in July 2018. WELL Health Technologies Corp. is headquartered in Vancouver, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2018‑10 | 2017‑10 | 2016‑10 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||